尼麦角林治疗后循环缺血性眩晕的疗效分析  

Analysis of the efficacy of nicergoline in the treatment of posterior circulation ischemic vertigo

作　　者：陆燕 LU Yan(.Peking University Care Luzhong Hospital,Zibo 255440,China)

机构地区：[1]北大医疗鲁中医院,255440

出　　处：《中国实用医药》2024年第15期123-125,共3页China Practical Medicine

摘　　要：目的探讨后循环缺血性眩晕(PCIV)患者应用尼麦角林治疗的临床效果。方法88例PCIV患者作为研究对象,按照信封法随机分为对照组和研究组,每组44例。对照组予以常规治疗,研究组在对照组基础上加用尼麦角林治疗。对比两组临床疗效及治疗前后血流动力学指标变化情况。结果研究组总有效率93.18%高于对照组的70.45%,有统计学意义(P<0.05)。治疗前,两组基底动脉、左侧椎动脉、右侧椎动脉血流速度对比无统计学意义(P>0.05);治疗后,两组基底动脉、左侧椎动脉、右侧椎动脉血流速度均优于治疗前,且研究组基底动脉血流速度(52.98±3.17)cm/s、左侧椎动脉血流速度(45.66±5.18)cm/s、右侧椎动脉血流速度(44.33±3.09)cm/s均优于对照组的(49.33±4.08)、(41.43±4.32)、(42.09±2.77)cm/s,有统计学意义(P<0.05)。结论将尼麦角林应用于PCIV患者临床治疗中效果显著,有利于改善其血流动力学相关指标。Objective To explore the clinical effect of nicergoline in the treatment of posterior circulation ischemic vertigo(PCIV).Methods A total of 88 patients with PCIV were selected as the subjects of this study.They were randomly grouped into a control group and a study group according to envelope method,with 44 cases in each group.The control group was given conventional treatment,and the study group was given nicergoline on the basis of the control group.The clinical efficacy and changes of hemodynamic indexes before and after treatment were compared between the two groups.Results The total effective rate of the study group was 93.18%,which was higher than 70.45%of the control group,and there was statistical significance(P<0.05).Before treatment,there was no statistical significance in blood flow velocity of basilar artery,left vertebral artery and right vertebral artery between the two groups(P>0.05).After treatment,the blood flow velocity of basilar artery,left vertebral artery and right vertebral artery in both groups was better than those before treatment;in the study group,the blood flow velocity of the basal artery was(52.98±3.17)cm/s,the blood flow velocity of the left vertebral artery was(45.66±5.18)cm/s and the blood flow velocity of the right vertebral artery was(44.33±3.09)cm/s,which were better than(49.33±4.08),(41.43±4.32)and(42.09±2.77)cm/s in the control group;there was statistical significance(P<0.05).Conclusion The application of nicergoline in the clinical treatment of PCIV patients has a significant effect,which is beneficial to improve the hemodynamic related indexes.

关 键 词：椎基底动脉 后循环缺血性眩晕 尼麦角林 

分 类 号：R743.3[医药卫生—神经病学与精神病学]